ANTENGENE CORPORATION
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research and drug production, enabling physicians to meet unmet medical needs in Asia.
ANTENGENE CORPORATION
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.antengene.com
Total Employee:
251+
Status:
Active
Contact:
+86 21 3250 1095
Total Funding:
238 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Mobile Non Scaleable Content Pound Sterling Japanese Yen COVID-19 China Telecom
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Life Biosciences
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Novogene
Novogene is a provider of genomic services and solutions with cutting edge NGS.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Sphere Fluidics
Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.
Current Advisors List
Board_member
Current Employees Featured
Jay Mei CEO & Founder @ Antengene Corporation
CEO & Founder
Hans de Haan Chief Medical Officer @ Antengene Corporation
Chief Medical Officer
Amily Zhang Chief Medical Officer @ Antengene Corporation
Chief Medical Officer
2022-12-01
Founder
Stock Details
Investors List
Hillhouse Investment
Hillhouse Investment investment in Series C - Antengene Corporation
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Antengene Corporation
GIC
GIC investment in Series C - Antengene Corporation
Boyu Capital
Boyu Capital investment in Series C - Antengene Corporation
Fidelity
Fidelity investment in Series C - Antengene Corporation
Taikang Insurance Group
Taikang Insurance Group investment in Series B - Antengene Corporation
FountainVest Partners
FountainVest Partners investment in Series B - Antengene Corporation
Boyu Capital
Boyu Capital investment in Series B - Antengene Corporation
TF Capital
TF Capital investment in Series B - Antengene Corporation
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Antengene Corporation
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-07 | Antengene Appoints Amily Zhang as its Chief Medical Officer |
Official Site Inspections
http://www.antengene.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.59 K
- Host name: 47.251.27.98
- IP address: 47.251.27.98
- Location: San Mateo United States
- Latitude: 37.5517
- Longitude: -122.33
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94402
More informations about "Antengene Corporation"
Antengene Corporation - Crunchbase Company Profile & Funding
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.The company focuses on providing patients with innovative anti-tumor and …See details»
Antengene - Overview, News & Similar companies | ZoomInfo.com
View Antengene (www.antengene.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Antengene - The Org
Driven by its vision of “Treating Patients Beyond Borders”, Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world.See details»
Antengene Corp. Ltd. - Drug pipelines, Patents, Clinical trials
Explore Antengene Corp. Ltd. with its drug pipeline, therapeutic area, technology platform, 34 clinical trials, 125 news, and 32 literature, Disease Domain:Neoplasms, Hemic and Lymphatic …See details»
Antengene - app.biopharmiq.com
Since 2017, Antengene has built a pipeline of 9 oncology programs at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region.See details»
Antengene | Digital Health Corporate Profiles | HealthTech Alpha
Antengene is a Pharmaceutical focused corporation. Discover digital health profiles, team, funding and valuation with HealthTech Alpha.See details»
Antengene - VentureRadar
"Antengene is a leading clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. We distinguish ourselves through our industry-leading R&D …See details»
Antengene: Revenue, Worth, Valuation & Competitors 2025
Antengene is a Pharmaceuticals related company founded in 2017 and based in Shanghai with 67 employees an estimated revenue of $18.3M, and. It has 10 competitors including Imaging …See details»
About Antengene
Corporate Social Responsibility Antengene is committed to fulfilling its corporate social responsibility by introducing novel and innovative oncology therapies for cancer patients and strives to discover new medical solutions to improve …See details»
Antengene Corp. Ltd. - BioCentury Company Profiles - BCIQ
Seven months after its $360 million IPO on the Hong Kong stock exchange, Shanghai-based Antengene Corp. Ltd. (HKEX:6996) is building out its pipeline with exclusive, worldwide …See details»
Antengene | Biotechnology | The Pharmaletter | The Pharmaletter
Antengene Corporation is a Chinese clinical-stage biopharmaceutical company focused on drug discovery, clinical development and the commercialization of innovative therapeutics to meet …See details»
Antengene Announces 2024 Full-Year Financial Results,
Accelerating Multi-market Revenue Ramp Up Shanghai and Hong Kong, PRC, March 21, 2025 — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) today announced its full-year …See details»
Antengene to Present Latest Results From Two Clinical Studies at …
Apr 24, 2025 Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, …See details»
Antengene - Advisory and Scientific Team | The Org
The Advisory and Scientific Team at Antengene provides expert guidance on pipeline strategy and project leadership, ensuring the development and delivery of cutting-edge anti-cancer …See details»
Our Business - Antengene
Clinical Development Antengene's clinical development team is composed of industry experts with deep global clinical development experience across the United States and Asia. The team has …See details»
Antengene Enters into a Global Clinical Collaboration with MSD to ...
1 day ago Antengene has built a pipeline of 9 oncology assets at various stages going from clinical to commercial, including 6 with global rights, and 3 with rights for the APAC region.See details»
Antengene Corporation - Contacts, Employees, Board Members, …
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.See details»
Newsroom - antengene.com
2 days ago Shanghai and Hong Kong, PRC, May 20, 2025 — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global …See details»
Newsroom - Antengene
Aug 25, 2023 Shanghai and Hong Kong, PRC, August 25, 2023 — Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), today announced its interim results for the six-months …See details»
Antengene & MSD Enter into a Global Clinical Collaboration
18 hours ago Antengene Corporation Limited (Antengene) has entered a global clinical collaboration with MSD (Merck & Co., Inc.) to evaluate the combination of ATG-022 and …See details»